Tovaxin for multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Tovaxin for multiple sclerosis.

Tovaxin for multiple sclerosis.

http://www.wikidata.org/entity/Q37874615

about

The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.Immunity and inflammation in neurodegenerative diseases.

P2860

Q38237315-422F700D-9564-49B8-815A-D2F7DABABD4A Q43104143-53A1B959-1A9A-474B-9859-7CF8B7D66A35

P2860

Tovaxin for multiple sclerosis.

http://www.wikidata.org/entity/Q37874615

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tovaxin for multiple sclerosis.

@en

Tovaxin for multiple sclerosis.

@nl

type

label

Tovaxin for multiple sclerosis.

@en

Tovaxin for multiple sclerosis.

@nl

prefLabel

Tovaxin for multiple sclerosis.

@en

Tovaxin for multiple sclerosis.

@nl

P1433

Q37874615-C8C70200-F111-4E89-83B5-3122E8D6CC9E

P1476

Q37874615-99E00047-8E52-45F7-BC7C-5DF839057B14

P2093

Q37874615-4F230B7D-4A06-40D2-84DD-7CC182F1696A

P2860

Q37874615-0153B01B-7B4F-43FE-BD40-C0EDF594E265

Q37874615-077070B2-E583-4672-9502-ACCA9529C5D2

Q37874615-0788FEEE-040B-4981-8A2A-02CE07854F5A

Q37874615-177D140F-2CD0-4C3F-95E5-616B412EED1B

Q37874615-183BA408-2B38-4569-B1BA-5E884482A4C9

Q37874615-1FCD5DC1-9D96-4B14-900F-B58020A2B7A8

Q37874615-398C1651-BD57-458F-8A61-017499E7D2A8

Q37874615-545DB9B3-1F42-40B6-B0EC-1DA42B1F6084

Q37874615-698AD667-B2B4-459B-A5B1-968A89D69430

Q37874615-73DE0EF2-3398-4D70-87FE-789F6F015552

P304

Q37874615-31B5923D-7340-449A-A097-C49E862A7BCB

P31

Q37874615-A0BDE36F-BCBD-4EF0-BB69-237E8C7907D5

P356

Q37874615-3FBDC088-5328-4807-803F-056B7B3B77FE

P407

Q37874615-C8BEFDD7-6B1B-43ED-9E65-BB6EE8996D8A

P433

Q37874615-E4A3644A-6587-4736-9254-12703EB7FF27

P478

Q37874615-39B59568-BB1A-4EDF-9E8A-DFF21216CD5C

P577

Q37874615-ED39307F-FCC5-4731-82C5-7EDE9EAA0F8C

P698

Q37874615-45D6334C-6EC4-4108-A24B-EDCF378F5461

P921

Q37874615-75DCB6B5-1C4E-4571-82A2-05077D2A7EDA

P356

14712598.2011.584866

P1433

Expert Opinion on Biological Therapy

P1476

Tovaxin for multiple sclerosis.

@en

P2093

Victor M Rivera

http://www.w3.org/2001/XMLSchema#string

P2860

Innate immunity in inflammatory bowel disease: a disease hypothesis

The role of the CD58 locus in multiple sclerosis

Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.

Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.

Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination.

Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination.

T cell vaccination in secondary progressive multiple sclerosis.

P304

961-967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2011.584866

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21563876

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis